Pa. Court Won't Rethink Upholding $4M Topamax Verdict
The Pennsylvania Superior Court has denied a Johnson & Johnson unit's bid to reconsider affirming a $4.2 million verdict in a birth defect suit related to epilepsy drug Topamax, standing by...To view the full article, register now.
Already a subscriber? Click here to view full article